What is AVAX Technologies, Inc. (AVXT) stock price today?

AVAX Technologies, Inc. (AVXT) is currently trading at $0.00.

What is AVXT P/E ratio?

AVAX Technologies, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AVXT return on equity (ROE)?

AVAX Technologies, Inc.'s return on equity (ROE) is -200.00%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is AVAX Technologies, Inc.'s market cap?

AVAX Technologies, Inc. has a market capitalization of $6894.

OTC · Biotechnology

AVAX Technologies, Inc. (AVXT) Stock

$0.00 OTC: AVXT Healthcare

AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy.

Valuation

Metric	Value
Price	$0.00
Market Cap	$6894
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.01
EPS (TTM)	$-0.05
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-200.00%
ROA	-85.71%
ROCE	197.81%
Gross Margin	700.00%
Operating Margin	700.00%
Net Margin	-600.00%
Debt/Equity	0.00
Current Ratio	1.50

Annual Financials (USD)

Metric	2003	2004	2005	2006	2007
Revenue	$1.0M	$2.0M	$2.0M	$1.0M	$1.0M
Operating Profit	$3.0M	$3.0M	$4.0M	$5.0M	$7.0M
Net Profit	$-3.0M	$-3.0M	$-4.0M	$-5.0M	$-6.0M
EPS	$-0.19	$-0.12	$-0.07	$-0.09	$-0.05
Op Margin	350.7%	197.5%	236.8%	748.4%	1084.1%

Balance Sheet (USD)

Metric	2003	2004	2005	2006	2007
Total Assets	$4.0M	$4.0M	$7.0M	$3.0M	$7.0M
Total Liabilities	$3.0M	$2.0M	$2.0M	$3.0M	$4.0M
Cash	$1.0M	$2.0M	$6.0M	$1.0M	$6.0M
Borrowings	$1.0M	$0	$0	$0	$0

Latest News

Why Corsair Gaming Stock Skyrocketed by 35% Today Motley Fool · Aug 7, 2026 Sweetgreen Stumbles Again. Are the Turnaround Chances Gone? Motley Fool · Aug 7, 2026 S.H.E. Pitch competition offers women-owned businesses opportunity The Frederick News-Post, Md. · Aug 7, 2026 Scott Bessent unveils new evidence that U.S. pressure on Iran is working TheStreet · Aug 7, 2026 Owner of Visitation Hotel sues Potomac Edison over power lines it says caused fire The Frederick News-Post, Md. · Aug 7, 2026

Cash Flow (USD)

Metric	2003	2004	2005	2006	2007
Operating Cash Flow	$-4.0M	$-3.0M	$-4.0M	$-4.0M	$-5.0M
Investing Cash Flow	$0	$0	$-1.0M	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-3.0M	$0	$4.0M	$-4.0M	$4.0M
Free Cash Flow	$-4.0M	$-3.0M	$-4.0M	$-4.0M	$-5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.96
FCF Yield	-70485.92%
Quick Ratio	1.61
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BRAXFBraxia Scientific Corp.	$0.00	—	-0.09	$28328	0.00%
DNAGDNAPrint Genomics, Inc.	$0.00	—	—	$12892	0.00%
INLBItem 9 Labs Corp.	$0.00	—	0.00	$70181	0.00%
IPAHInterpharm Holdings, Inc.	$0.00	—	—	$660	0.00%
JNHMFJack Nathan Medical Corp.	$0.00	—	-0.70	$87099	0.00%

About AVAX Technologies, Inc.

AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.

AVAX Technologies, Inc. (AVXT) stock trades at $0.00 with a market capitalization of $6894. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, AVAX Technologies, Inc. generates a return on equity (ROE) of -200.00%, return on capital employed of 197.81%, an operating margin of 700.00%, a net profit margin of -600.00%.

Official website: www.avax-tech.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides